Spectrum Management Group’s AstraZeneca AZN Stock Holding History

Spectrum Management Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-30	Closed	-$3K	–	229
2020 Q4	$3K	Sell	30 -17	-36%	-$1.8K	﹤0.01%	206
2020 Q3	$5K	Hold	47	–	–	﹤0.01%	229
2020 Q2	$5K	Hold	47	–	–	﹤0.01%	231
2020 Q1	$4K	Hold	47	–	–	﹤0.01%	222
2019 Q4	$5K	Sell	47 -53	-53%	-$4.99K	﹤0.01%	208
2019 Q3	$9K	Hold	100	–	–	﹤0.01%	186
2019 Q2	$8K	Hold	100	–	–	﹤0.01%	199
2019 Q1	$8K	Hold	100	–	–	﹤0.01%	221
2018 Q4	$8K	Hold	100	–	–	﹤0.01%	183
2018 Q3	$8K	Hold	100	–	–	﹤0.01%	182
2018 Q2	$7K	Buy	+100	New	+$7.19K	﹤0.01%	187

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Spectrum Management Group's AZN Position: Q1 2021 in Review

Spectrum Management Group sold out of AstraZeneca (AZN) in Q1 2021, closing a stake of 30 shares — an estimated $3K sold.

Spectrum Management Group first reported a position in AZN in Q2 2018 and held it in 11 quarters. The position peaked at $9K in Q3 2019. 756 funds tracked by Wall St. Rank hold AZN as of Q1 2021.

Spectrum Management Group reported no remaining AstraZeneca position as of Q1 2021 after selling out during the quarter.
Spectrum Management Group sold 30 AstraZeneca shares in Q1 2021, an estimated $3K.
Spectrum Management Group first reported a position in AstraZeneca in Q2 2018 and held it in 11 quarters.
Spectrum Management Group's AstraZeneca position peaked at $9K in Q3 2019.
756 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2021.

Based on Spectrum Management Group's 13F filing for Q1 2021, filed 6 May 2021.